InMode (NASDAQ:INMD) released its quarterly earnings data on Tuesday. The healthcare company reported $0.46 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.07, Briefing.com reports. The firm had revenue of $47.00 million during the quarter, compared to analyst estimates of $42.48 million. InMode had a return on equity of 50.50% and a net margin of 30.33%. The business’s quarterly revenue was up 63.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.22 earnings per share. InMode updated its FY20 guidance to $1.85-1.93 EPS and its FY 2020
Pre-Market guidance to 1.85-1.93 EPS.
Shares of InMode stock opened at $40.69 on Wednesday. The company’s 50 day moving average price is $43.27. InMode has a 12 month low of $13.06 and a 12 month high of $58.76. The company has a debt-to-equity ratio of 0.01, a current ratio of 7.83 and a quick ratio of 7.47.
A number of equities analysts recently commented on INMD shares. Zacks Investment Research lowered InMode from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, January 8th. Canaccord Genuity reissued a “buy” rating and set a $50.00 price target on shares of InMode in a research note on Wednesday. Barclays increased their price target on InMode from $27.00 to $45.00 and gave the company an “overweight” rating in a research note on Wednesday, November 6th. Finally, Robert W. Baird reissued an “outperform” rating and set a $55.00 price target (up from $45.00) on shares of InMode in a research note on Tuesday, January 28th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $44.60.
InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radio frequency technologies. The company offers minimally-invasive aesthetic medical products for procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments.
See Also: What is Depreciation?
Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.